Janet Zierer
Nurse Practitioner · Spokane Valley, WANPI 1760431290
Payments from drug & device makers
Across 114 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$316
- Vifor Pharma, Inc.$237
- Novartis$199
- AstraZeneca$169
- GSK$169
- Ardelyx, Inc.$149
- plus $732 from 12 others
What the payments were for
- Food & beverage$1,969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 25 | $316 |
| Vifor Pharma, Inc. | 12 | $237 |
| Novartis | 9 | $199 |
| AstraZeneca | 8 | $169 |
| GSK | 16 | $169 |
| Ardelyx, Inc. | 9 | $149 |
| Amgen | 7 | $131 |
| Novo Nordisk | 6 | $130 |
| Lilly USA, LLC | 6 | $115 |
| Calliditas Therapeutics US Inc. | 5 | $90 |
| Travere Therapeutics, Inc. | 2 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Mannkind Corporation | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
| Akebia Therapeutics Inc | 1 | $14 |
How this compares
$1,969 in reported general payments places this provider in the 90th percentile of 2,466 nurse practitioner providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $60,273 |
| JardianceEmpagliflozin | 36 | $36,474 |
| XareltoRivaroxaban | 20 | $18,990 |
| FarxigaDapagliflozin Propanediol | 11 | $11,088 |
| OzempicSemaglutide | 11 | $10,296 |
| Cinacalcet Hcl | 18 | $6,078 |
| Potassium Chloride | 129 | $2,894 |
| Torsemide | 111 | $2,458 |
| Desmopressin AcetateDesmopressin (Nonrefrigerated) | 17 | $2,177 |
| Irbesartan | 63 | $1,728 |
| Chlorthalidone | 76 | $1,468 |
| Carvedilol | 173 | $1,252 |
| Metoprolol Succinate | 76 | $1,219 |
| Potassium Citrate ErPotassium Citrate | 15 | $1,027 |
| Atorvastatin Calcium | 72 | $807 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $169 | $11,08811 claims |
| Novo NordiskOzempic | $130 | $10,29611 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $52 | $52114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,466 nurse practitioner providers in Washington.
Other nurse practitioner in Spokane Valley
- Jennifer LazzaraSpokane Valley$11K
- Darla ChapmanSeattle$541K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Wayne ClarkYakima$232K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.